135 related articles for article (PubMed ID: 32366552)
41. Prognostic impact of C-reactive protein in metastatic prostate cancer: a systematic review and meta-analysis.
Rocha P; Morgan CJ; Templeton AJ; Pond GR; Naik G; Sonpavde G
Oncol Res Treat; 2014; 37(12):772-6. PubMed ID: 25531724
[TBL] [Abstract][Full Text] [Related]
42. Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis.
Zhang L; Zha Z; Qu W; Zhao H; Yuan J; Feng Y; Wu B
BMC Cancer; 2018 Sep; 18(1):870. PubMed ID: 30176824
[TBL] [Abstract][Full Text] [Related]
43. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
[TBL] [Abstract][Full Text] [Related]
44. Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.
Qi XW; Zhang F; Wu H; Liu JL; Zong BG; Xu C; Jiang J
Sci Rep; 2015 Mar; 5():8924. PubMed ID: 25748047
[TBL] [Abstract][Full Text] [Related]
45. The Prognostic Value of Pretreatment Plasma Fibrinogen in Urological Cancers: A Systematic Review and Meta-analysis.
Song H; Kuang G; Zhang Z; Ma B; Jin J; Zhang Q
J Cancer; 2019; 10(2):479-487. PubMed ID: 30719143
[No Abstract] [Full Text] [Related]
46. The prognostic value of AGR2 expression in solid tumours: a systematic review and meta-analysis.
Tian SB; Tao KX; Hu J; Liu ZB; Ding XL; Chu YN; Cui JY; Shuai XM; Gao JB; Cai KL; Wang JL; Wang GB; Wang L; Wang Z
Sci Rep; 2017 Nov; 7(1):15500. PubMed ID: 29138453
[TBL] [Abstract][Full Text] [Related]
47. The impact of PTEN deletion and ERG rearrangement on recurrence after treatment for prostate cancer: a systematic review and meta-analysis.
Liu R; Zhou J; Xia S; Li T
Clin Transl Oncol; 2020 May; 22(5):694-702. PubMed ID: 31359337
[TBL] [Abstract][Full Text] [Related]
48. Elevated inflammatory parameters and inflammation scores are associated with poor prognosis in patients undergoing pulmonary metastasectomy for colorectal cancer.
Ghanim B; Schweiger T; Jedamzik J; Glueck O; Glogner C; Lang G; Klepetko W; Hoetzenecker K
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):616-23. PubMed ID: 26242317
[TBL] [Abstract][Full Text] [Related]
49. High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer.
Lobo J; Rodrigues Â; Antunes L; Graça I; Ramalho-Carvalho J; Vieira FQ; Martins AT; Oliveira J; Jerónimo C; Henrique R
Urol Oncol; 2018 Apr; 36(4):161.e7-161.e17. PubMed ID: 29174711
[TBL] [Abstract][Full Text] [Related]
50. C-Reactive Protein is a Prognostic Marker for Patients with Castration-Resistant Prostate Cancer.
Liao SG; Cheng HH; Lei Y
Oncol Res Treat; 2016; 39(5):266-71. PubMed ID: 27174032
[TBL] [Abstract][Full Text] [Related]
51. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
Li Y; Liu X; Zhang J; Yao W
Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
[TBL] [Abstract][Full Text] [Related]
52. C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review.
Shrotriya S; Walsh D; Bennani-Baiti N; Thomas S; Lorton C
PLoS One; 2015; 10(12):e0143080. PubMed ID: 26717416
[TBL] [Abstract][Full Text] [Related]
53. Pretreatment elevated prognostic nutritional index predicts a favorable prognosis in patients with prostate cancer.
Li B; Lu Z; Wang S; Hou J; Xia G; Li H; Yin B; Lu W
BMC Cancer; 2020 Apr; 20(1):361. PubMed ID: 32349713
[TBL] [Abstract][Full Text] [Related]
54. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis.
Woo HD; Kim K; Kim J
Cancer Causes Control; 2015 Nov; 26(11):1661-70. PubMed ID: 26376895
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis.
Li D; Lv H; Hao X; Hu B; Song Y
Cancer Manag Res; 2018; 10():3125-3139. PubMed ID: 30214305
[TBL] [Abstract][Full Text] [Related]
56. Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase Ratio) in Urological Cancers: A Systematic Review and Meta-Analysis.
Su S; Liu L; Li C; Zhang J; Li S
Front Oncol; 2020; 10():1650. PubMed ID: 33014827
[No Abstract] [Full Text] [Related]
57. Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysis.
Zhang W; Zhang Z; Qian L
World J Surg Oncol; 2024 Jan; 22(1):8. PubMed ID: 38172843
[TBL] [Abstract][Full Text] [Related]
58. The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review.
Chen Q; Zhong T
Drug Des Devel Ther; 2015; 9():5115-22. PubMed ID: 26379424
[TBL] [Abstract][Full Text] [Related]
59. The significance of microRNA-148/152 family as a prognostic factor in multiple human malignancies: a meta-analysis.
Miao C; Zhang J; Zhao K; Liang C; Xu A; Zhu J; Wang Y; Hua Y; Tian Y; Liu S; Zhang C; Qin C; Wang Z
Oncotarget; 2017 Jun; 8(26):43344-43355. PubMed ID: 28574848
[TBL] [Abstract][Full Text] [Related]
60. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
